8225 — China Health Income Statement
0.000.00%
Last trade - 00:00- HK$147.31m
- HK$129.72m
- CNY26.45m
- 40
- 19
- 60
- 32
Annual income statement for China Health, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 83.1 | 83.6 | 13.1 | 21.4 | 26.5 |
| Cost of Revenue | |||||
| Gross Profit | 67 | 63.9 | 5.74 | 8.21 | 10.1 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 12.1 | 41.1 | 28.9 | 79.6 | 40.9 |
| Operating Profit | 71 | 42.5 | -15.8 | -58.2 | -14.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 70.8 | 42.5 | -15.8 | -58.2 | -14.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 60.6 | 36.3 | -15.8 | -58.2 | -14.5 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 60.6 | 36.3 | -15.8 | -58.2 | -14.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 60.6 | 36.3 | -15.8 | -58.2 | -14.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.047 | 0.039 | -0.016 | -0.058 | -0.015 |